-
Most Popular
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Recent Healthcare Stocks Articles
3 Biggest Ways AI Stocks are Changing the Game
Most people think of the artificial intelligence (AI) revolution as something that’s theoretical — a technology that will affect things in the future. In actuality, though, it is already happening.
Why Canopy Growth’s Deals May Not Translate Into Gains for CGC Stock
The Acreage deal as well as the agreement with PharmHouse will boost Canopy Growth, but it may not translate into gains for CGC stock.
This Cannabis Company Will Probably End Up in the Dustbin of Wall Street History
Marijuana stocks lose money, and Cannabis Sativa (CBDS) is no different. However, it may still be a profitable short-term investment.
Tilray Stock Is Red-Hot, But It’s Fundamentally Flawed
Tilray stock jumped on a solid Q1 earnings report, but it still can't escape marijuana's hype machine.
This Marijuana Stock Could Make a Dramatic Move
Most of the technical analysis I see is terrible, but there's validity to some aspects of the discipline. See why with this marijuana stock chart.
4 Pot Stocks to Own for Full-Blown Federal Marijuana Reform
A few months ago, I was thinking that medical marijuana would become legal in the United States by 2023, with recreational use to follow a few years later. I now expect it to be much sooner than that. And everyone who owns cannabis stocks stands to benefit.
6 Signs That Marijuana Legalization is Closer Than You Think
Based on the facts, news, and trends – not a gut feeling for or against marijuana – I expect legalization soon. And I've got six reasons why.
Why I Regret Buying Cronos Group Stock
My investment in Cronos Group should be a lesson to investors buying into the hype. If CRON stock manages to pop on earnings, take profits!
Wait for Earnings Before Trading Aurora Cannabis Stock
ACB stock has seen little activity over the last few weeks, but earnings should give investors some clarity on the near-term direction of ACB.
Canopy Growth Stock Will Fall Off as Marijuana Investors Realize Their Mistake
Canopy Growth has been red hot since the middle of last year, but CGC stock will have to start making good money, and soon.
2 Under-The-Radar Cannabis Stocks with Significant Growth Potential
HEXO stock and SPRWF stock are less crowded trades than some of the more popular cannabis stocks. With relatively small market caps, the two stocks may have even more of a long-term growth opportunity than their larger peers.
A New Frontier for CRISPR Stocks: Gene Therapy Cures 10 Babies
Scientists took out stem cells from the babies and used a modified HIV virus to deliver the “corrected” copy of the gene back into the patient. It cured the babies with no apparent side effects. This is huge.
A Game-Changing Moment for Marijuana Stocks Just Got Closer
The biggest marijuana company in the world and some of the most connected people in the world all but told us that U.S. marijuana legalization is coming… and perhaps sooner than expected.
This Is Why Canopy Growth Is the Best Pot Stock
Through a deal with Acreage, CGC stock has an opportunity to dominate the U.S. cannabis market like its dominated the Canadian market.